Kolera

01Pathophysiology

Vibrio cholerae is acquired through the fecal-oral route, almost always from contaminated water or food. The organism must survive the acidic environment of the stomach to reach the small intestine, which is why patients with reduced gastric acidity (from proton pump inhibitors, prior gastrectomy, or chronic atrophic gastritis) are at higher risk. Once in the small intestine, the bacterium colonizes the mucosal surface using the toxin-coregulated pilus (TCP) but does not invade the epithelium. This is a critical concept: cholera is a non-invasive, non-inflammatory diarrhea. The mucosa remains structurally intact, which is why you will never see blood, mucus, or fecal leukocytes in the stool.

The virulence of cholera is driven almost entirely by cholera toxin, which is an AB₅ enterotoxin. The five B subunits bind to the GM1 ganglioside receptor on the surface of intestinal epithelial cells, allowing the enzymatically active A subunit to enter the cell. Once inside, the A1 fragment catalyzes ADP-ribosylation of the Gs alpha subunit of the stimulatory G-protein. This locks the Gs protein in a permanently "on" state, causing constitutive activation of adenylate cyclase. The result is a sustained and irreversible increase in intracellular cyclic AMP (cAMP).

Elevated cAMP opens the CFTR (cystic fibrosis transmembrane conductance regulator) chloride channels on the luminal surface of enterocytes. Chloride ions pour into the intestinal lumen, and sodium and water follow passively. This produces the characteristic voluminous secretory diarrhea. A single patient can lose 10 to 20 liters of fluid per day, leading to isotonic dehydration, hypovolemic shock, and death within hours if untreated. The bicarbonate-rich nature of the stool losses explains the non-anion gap metabolic acidosis, while concurrent potassium losses drive hypokalemia, which can cause muscle cramps and cardiac arrhythmias.

The connection between pathophysiology and the exam is direct. Whenever you see a vignette asking about the mechanism of a toxin that increases cAMP, think cholera toxin and its ADP-ribosylation of the Gs protein. Contrast this with pertussis toxin, which also ADP-ribosylates a G-protein but targets the Gi (inhibitory) subunit, and with E. coli heat-labile toxin (LT), which has a mechanism essentially identical to cholera toxin.

02Classification and Clinical Manifestation

Cholera severity is classified by the WHO dehydration grading system, which directly guides treatment decisions:

Clinical manifestations can also be categorized by the serogroup and biotype:

03Diagnostic Workup

In a clinical vignette, you will rarely be asked to "diagnose" cholera based on a single lab test in isolation. Instead, the diagnosis is typically clinical: the combination of profuse, painless, rice-water diarrhea in a patient with recent travel to an endemic area should immediately trigger the diagnosis before any labs return. The best initial step in a severely dehydrated patient is not ordering a culture; it is starting IV fluids. This is a commonly tested concept: stabilize first, diagnose second.

When confirmatory testing is the focus of the question, stool culture on TCBS agar is the gold standard. The yellow colonies (sucrose fermentation) are a high-yield visual detail. For serotyping and outbreak investigations, slide agglutination with O1 and O139 antisera is performed on the cultured isolate.

Note the stool findings that help you rule out inflammatory or invasive causes: the absence of fecal leukocytes and the absence of blood. This separates cholera (and other secretory diarrheas caused by enterotoxigenic organisms) from invasive pathogens like Shigella, Salmonella, Campylobacter, and Entamoeba histolytica, all of which produce bloody or mucoid stools with fecal WBCs.

04Management and Treatment

The single most important concept in cholera management is that rehydration is the treatment. Antibiotics are adjunctive; they reduce stool volume and duration but are never the "next best step" ahead of fluid replacement. On the exam, if you are given a patient in hypovolemic shock from cholera and asked for the next best step, the answer is IV Ringer's lactate, not antibiotics. Normal saline is acceptable but less ideal because it does not correct the concurrent metabolic acidosis (Ringer's lactate contains lactate, which is metabolized to bicarbonate).

Once the patient is hemodynamically stable and can tolerate oral intake, transition to ORS. The science behind ORS is itself a commonly tested topic: glucose in the solution activates the sodium-glucose cotransporter (SGLT1) on the intestinal brush border, which allows sodium and water absorption even while the CFTR chloride channels remain open from cholera toxin. This is why ORS works and why plain water alone does not adequately rehydrate.

For antibiotic selection, doxycycline is first-line in adults. It is contraindicated in pregnancy and in children under 8 years old due to the risk of permanent tooth discoloration and impaired bone growth. In these populations, azithromycin is the preferred alternative. If a vignette describes a pregnant woman with severe cholera, the answer for antibiotic therapy is azithromycin, not doxycycline.

Potassium replacement should be guided by serum levels. Hypokalemia is expected and should be corrected to prevent cardiac complications (prolonged QT, U waves, risk of arrhythmia).

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common mistake students make with cholera questions is choosing antibiotics as the first step in management when the patient is severely dehydrated or in shock. The exam tests whether you understand that cholera kills through dehydration, not through bacterial invasion. The mortality of untreated severe cholera can exceed 50%, but with appropriate fluid replacement alone, it drops to below 1%. Antibiotics help, but they are never the priority over restoring intravascular volume.

A second frequent trap involves the mechanism of cholera toxin. Students confuse the target of ADP-ribosylation. Cholera toxin ribosylates the Gs (stimulatory) alpha subunit, leading to increased cAMP. Pertussis toxin also performs ADP-ribosylation, but it targets the Gi (inhibitory) alpha subunit, which also results in increased cAMP but through a different mechanism (loss of inhibition rather than constitutive activation). If a question stem describes a toxin that "ADP-ribosylates a G-protein" and asks you to identify the target, read carefully for whether it specifies "stimulatory" or "inhibitory."

A third pearl concerns the CFTR channel. The same chloride channel that is hijacked by cholera toxin is the one that is dysfunctional in cystic fibrosis. This molecular link explains a tested association: heterozygous carriers of CFTR mutations may have a survival advantage against cholera (and other secretory diarrheas) because their partially impaired chloride secretion limits fluid losses. This is analogous to the sickle cell trait conferring protection against malaria.

Finally, remember the stool appearance. "Rice-water" is the single most recognizable buzzword for cholera. If a vignette describes a patient with voluminous, pale, flecked, watery stool that resembles water in which rice has been washed, with no blood and no inflammatory cells, the answer is cholera until proven otherwise. The core competency being tested is pattern recognition of a classic infectious disease presentation paired with the ability to prioritize resuscitation over all other interventions.